Wednesday, October 17, 2018
 
 
Company News: Page (1) of 1 - 07/08/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Benitec Announces Global Licensing Agreement for BB-301 for Treatment of Oculopharyngeal Muscular Dystrophy and Broad Platform Collaboration with Axovant
- Benitec to receive upfront cash payment of US$10 million with additional cash payments totalling US$17.5 million (a total of US$27.5M) upon completion of near-term milestones for BB-301, now named A...
(July 08, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords:Medicine,Disease,Cancer,Surgery,Medication,Science,Medical,Biology,Genetics,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines